Related Experiment Video
Updated: Jul 17, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine
Stephen M Rosenthal1, Brian J Feldman, Gabriel A Vargas
1University of California, San Francisco.
Abstract:
Mutations of G protein-coupled receptors are responsible for a wide range of diseases. With respect to water balance and vasopressin signaling, more than 180 different inactivating mutations have been previously described in the V2 vasopressin receptor (V2R), resulting in nephrogenic diabetes insipidus. In contrast, we have recently described the first known patients with V2R activating mutations. Patients with these novel gain-of-function V2R mutations have a disorder which we have termed "nephrogenic syndrome of inappropriate antidiuresis" (NSIAD): a clinical presentation consistent with the syndrome of inappropriate antidiuretic hormone secretion but with undetectable levels of arginine vasopressin (antidiuretic hormone). The mechanisms by which these mutations constitutively activate the V2R are currently being investigated.
Insights
Gain-of-function mutations in the V2 vasopressin receptor cause nephrogenic syndrome of inappropriate antidiuresis (NSIAD). This condition mimics Syndrome of Inappropriate Antidiuretic Hormone secretion but lacks elevated vasopressin levels.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- G protein-coupled receptors, including the V2 vasopressin receptor (V2R), are implicated in numerous diseases.
- Over 180 inactivating V2R mutations cause nephrogenic diabetes insipidus, a disorder of water balance.
- Previously, only inactivating V2R mutations were known.
Purpose of the Study:
- To describe a novel disorder caused by activating V2R mutations.
- To introduce the term "nephrogenic syndrome of inappropriate antidiuresis" (NSIAD).
- To characterize the clinical presentation and underlying molecular mechanisms of NSIAD.
Main Methods:
- Clinical case description of patients with V2R activating mutations.
- Biochemical analysis to assess vasopressin levels.
- Molecular studies to investigate V2R constitutive activation (ongoing).
Main Results:
- Identified the first patients with V2R activating mutations.
- Described a new clinical entity, NSIAD, characterized by features of SIAD.
- Patients presented with undetectable arginine vasopressin levels despite NSIAD symptoms.
Conclusions:
- Activating V2R mutations lead to NSIAD, a distinct clinical syndrome.
- NSIAD presents similarly to SIAD but is caused by V2R dysfunction, not excess vasopressin.
- Further research is needed to elucidate the mechanisms of V2R constitutive activation by these mutations.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Diabetes Insipidus II: Pathophysiology
Diabetes Insipidus I: Introduction
Antihypertensive Drugs: Potassium-Sparing Diuretics
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Nephrons
